ArticleLung cancer management2026

Cost of managing brain metastases in ALK-positive advanced NSCLC patients receiving first-line ALK TKIs in China.

Bingqi Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.